expect to see some traction in biocon in h2; like gland pharma among injectables: sanford bernstein
Published 7 months ago • 979 plays • Length 8:03Download video MP4
Download video MP3
Similar videos
-
1:52
biocon initiates talks for potential stake sale in biosimilar arm & syngene | et now exclusive
-
1:38
advancing aortic procedures with philips vesselnavigator
-
1:03
focused on the patient
-
1:04
stelo by dexcom, the first over-the-counter glucose biosensor in the u.s., is now available
-
7:26
philips intellispace portal 7.0 clinical application mr neurology
-
13:56
regulatory cmc for bio-pharma and pharmaceuticals
-
2:43
cyton biosensing tutorial
-
3:47
cardiology that clicks - boehringer ingelheim sponsored webinar series
-
1:07
why egps now more than ever - efficiency through planning
-
1:28
siemens syngo dynapbv body - insight into perfusion - workflow
-
3:22
ge healthcare showcases new cardiovascular it innovations - hrs san francisco | ge healthcare
-
0:54
get the complete picture: ut health san antonio - physician teaser 3 economic value
-
0:41
recent advances in understanding and managing ctcl
-
2:27
importance of scalable cell therapy manufacturing processes
-
2:39
what do the brainxpert energy complex study results show?
-
1:00
the visible skeleton 2.0
-
6:40
"you could discover something absolutely groundbreaking"
-
1:38
today at #bps20 – monday
-
0:24
elevate neuro diagnostics, with philips mr neuro imaging- teaser
-
1:24
extracellular protein fibulin-7 and its c-terminal fragment have in vivo antiangiogenic activity
-
6:40
where cmc starts in biopharma drug dev